Andrés Rosales is an experienced professional currently serving on the Investment Team at 8VC since July 2024. Previously, Andrés participated in the Longevity Biotech Fellowship in 2024 and worked as a Business Analyst at McKinsey & Company from 2022 to 2024. Under the role of Strategy/Operations, Andrés contributed at Atomic from 2021 to 2022 while also serving as a Teaching Fellow for Engineering Sciences 95R - Startup R&D at Harvard John A. Paulson School of Engineering and Applied Sciences. As a Co-Founder of Keto Kare, which focuses on medical foods for metabolic health, Andrés was involved from 2020 to 2022. Additional experience includes a brief tenure as a Machine Learning Engineer at Dyno Therapeutics in 2021, and conducting proteomics research at Harvard Medical School in 2020. Andrés holds a Bachelor of Arts in Applied Mathematics and Physics from Harvard University, with experience in cross-registration at the Massachusetts Institute of Technology.